Literature DB >> 18980795

Beta-mannosidosis: a new cause of spinocerebellar ataxia.

Pierre Labauge1, Dimitri Renard, Giovanni Castelnovo, Frédérique Sabourdy, Nicolas de Champfleur, Thierry Levade.   

Abstract

Beta-mannosidosis (OMIM 248510) is an inborn lysosomal storage disorder caused by deficiency of beta-mannosidase activity. This enzyme is encoded by a single gene (MANBA), located on chromosome 4q22-25. This autosomal recessive disorder is characterized by a wide range of symptoms including mental retardation, behavioural problems, hearing loss, recurrent respiratory infections, angiokeratoma, facial dysmorphism, skeletal deformation, seizures, hypotonia, demyelinating polyneuropathy, and hepatosplenomegaly. The age of symptom onset is variable. We describe a 14-year clinical follow-up of a patient with beta-mannosidase deficiency with symptoms of mental retardation, progressive spasticity and cerebellar ataxia, a clinical spectrum that so far has never been reported in beta-mannosidosis. A novel mutation in the MANBA gene was found in our patient. Evoked potentials were in favour of a demyelinating pathology of the central nervous system. Serial MRI showed generalized cortical and subcortical atrophy in the absence of white matter changes suggesting an additional axonal pathophysiological component.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980795     DOI: 10.1016/j.clineuro.2008.09.007

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  12 in total

1.  Skeletal and Brain Abnormalities in Fucosidosis, a Rare Lysosomal Storage Disorder.

Authors:  Camille Malatt; Jeffrey L Koning; John Naheedy
Journal:  J Radiol Case Rep       Date:  2015-05-31

2.  Hereditary β-mannosidosis in a dog: Clinicopathological and molecular genetic characterization.

Authors:  Pompei Bolfa; Ping Wang; Rajeev Nair; Sreekumari Rajeev; Anibal G Armien; Paula S Henthorn; Tim Wood; Mary Anna Thrall; Urs Giger
Journal:  Mol Genet Metab       Date:  2019-08-10       Impact factor: 4.797

3.  A Clinically Severe Variant of β-Mannosidosis, Presenting with Neonatal Onset Epilepsy with Subsequent Evolution of Hydrocephalus.

Authors:  A Broomfield; R Gunny; I Ali; A Vellodi; P Prabhakar
Journal:  JIMD Rep       Date:  2013-04-16

Review 4.  Mental retardation and inborn errors of metabolism.

Authors:  A García-Cazorla; N I Wolf; M Serrano; U Moog; B Pérez-Dueñas; P Póo; M Pineda; J Campistol; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2009-08-14       Impact factor: 4.982

5.  Ataxia telangiectasia alters the ApoB and reelin pathway.

Authors:  Júlia Canet-Pons; Ralf Schubert; Ruth Pia Duecker; Roland Schrewe; Sandra Wölke; Matthias Kieslich; Martina Schnölzer; Andreas Chiocchetti; Georg Auburger; Stefan Zielen; Uwe Warnken
Journal:  Neurogenetics       Date:  2018-10-21       Impact factor: 2.660

6.  Lysosomal storage disease in the brain: mutations of the β-mannosidase gene identified in autosomal dominant nystagmus.

Authors:  Ping Yu; Yun Cui; Wanshi Cai; Honghu Wu; Xiaoqiang Xiao; Qianzhi Shao; Liang Ma; Sen Guo; Nana Wu; Zi-Bing Jin; Yongjin Wang; Tao Cai; Zhong Sheng Sun; Jia Qu
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

7.  β-Mannosidosis caused by a novel homozygous intragenic inverted duplication in MANBA.

Authors:  Maria Blomqvist; Marie Falkenberg Smeland; Julia Lindgren; Per Sikora; Hilde Monica Frostad Riise Stensland; Jorge Asin-Cayuela
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-06-03

8.  Clinical implementation of gene panel testing for lysosomal storage diseases.

Authors:  Alexander Gheldof; Sara Seneca; Katrien Stouffs; Willy Lissens; Anna Jansen; Hilde Laeremans; Patrick Verloo; An-Sofie Schoonjans; Marije Meuwissen; Diana Barca; Geert Martens; Linda De Meirleir
Journal:  Mol Genet Genomic Med       Date:  2018-12-11       Impact factor: 2.183

9.  Biochemical and clinical response after umbilical cord blood transplant in a boy with early childhood-onset beta-mannosidosis.

Authors:  Troy C Lund; Weston P Miller; Julie B Eisengart; Katrina Simmons; Laura Pollard; Deborah L Renaud; David A Wenger; Marc C Patterson; Paul J Orchard
Journal:  Mol Genet Genomic Med       Date:  2019-05-21       Impact factor: 2.183

10.  A MANBA mutation resulting in residual beta-mannosidase activity associated with severe leukoencephalopathy: a possible pseudodeficiency variant.

Authors:  Frédérique Sabourdy; Pierre Labauge; Hilde Monica Frostad Riise Stensland; Michèle Nieto; Violeta Latorre Garcés; Dimitri Renard; Giovanni Castelnovo; Nicolas de Champfleur; Thierry Levade
Journal:  BMC Med Genet       Date:  2009-09-03       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.